Evaluate the Efficacy and Safety of ACTIQ in Patients With Cancer and Breakthrough Pain
This study has been completed.
Sponsor:
Cephalon
Information provided by (Responsible Party):
Teva Pharmaceutical Industries ( Cephalon )
ClinicalTrials.gov Identifier:
NCT00236145
First received: October 7, 2005
Last updated: January 28, 2013
Last verified: October 2005
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Primary Completion Date: | August 2005 (Final data collection date for primary outcome measure) |